Autori: Foldes Joseph A
Naslov | Significant, Continuous Improvement in Bone Mineral Density (Bmd) Among Type 1 Gaucher Disease Patients Treated with Velaglucerase Alfa: 69-Month Experience, Including Dose Reduction (Meeting Abstract) |
Autori | Elstein Deborah Foldes Joseph A Zahrieh David Cohn Gabriel M Djordjevic Maja S Brutaru Costin Zimran An |
Info | JOURNAL OF INHERITED METABOLIC DISEASE, (2011), vol. 34 br. , Suppl. 3, str. S223-S223 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction (Article) |
Autori | Elstein Deborah Foldes Joseph A Zahrieh David Cohn Gabriel M Djordjevic Maja S Brutaru Costin Zimran Ari |
Info | BLOOD CELLS MOLECULES AND DISEASES, (2011), vol. 47 br. 1, str. 56-61 |
Projekat | Shire Human Genetic Therapies ; Protalix Therapeutics ; Genzyme Corporation |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Significant, continuous improvement in Bone Mineral Density (BMD) among type 1 Gaucher disease patients treated with Velaglucerase Alfa: 69-month experience, including dose reduction (Meeting Abstract) |
Autori | Elstein Deborah Foldes Joseph A Zahrieh David Cohn Gabriel M Djordjevic Maja S Brutaru Costin Zimran An |
Info | MOLECULAR GENETICS AND METABOLISM, (2011), vol. 102 br. 2, str. S17-S18 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|